The proportion of patients who had recurrent pericarditis was 26 ( 216 % ) of 120 in the colchicine group and 51 ( 425 % ) of 120 in the placebo group ( relative risk 049 ; 95 % CI 024-065 ; p = 00009 ; number needed to treat 5 ) .